UCLB in Conversation with Apollo Therapeutics

Anne Lane, CEO of UCLB, is joined by Apollo Therapeutics, a first of its kind portfolio-based spinout powered by an alliance of three world leading universities, backed by investors and industry expertise. Anne is joined by Richard Mason, CEO of…

0
(0)

Anne Lane, CEO of UCLB, is joined by Apollo Therapeutics, a first of its kind portfolio-based spinout powered by an alliance of three world leading universities, backed by investors and industry expertise.

Anne is joined by Richard Mason, CEO of Apollo Therapeutics, Richard Fagan, Director of BioPharm at UCLB, Stephanie Morris, Director of Industry Partnerships and Commercialisation in Medicine at Imperial College London and Iain Thomas, Head of Life Sciences at Cambridge Enterprise. The panel discuss the journey of developing Apollo Therapeutics, and what’s next for this exciting company.

0 / 5. 0